A project team received the insights it needed on the go-to-market strategy for cell and gene therapy drugs. GLG helped team members understand how these drugs will be priced so they could successfully advise their client.
Custom Recruiting
GLG sourced 42 respondents that included VPs at pharma companies, directors of pharmacy policy, professionals in behavioral pharmacy solutions, and healthcare payment model experts.
Project Breadth
1 survey with 42 respondents
Challenge
A project team at a professional services firm wanted to know how pharmaceutical companies manage cell and gene therapy drugs. They wanted to hear from senior pharmaceutical professionals to understand how these types of drugs will be priced and brought to market.
The GLG Approach
To gauge the market for cell and gene therapy drugs, GLG designed and ran a B2B survey targeting 42 executives who oversee pharmacy business units for payors.
The survey answers gave the client an understanding of typical cell and gene therapy drug go-to-market strategies, including approaches to projecting drug utilization.
Outcome
This survey gave the client's project team an understanding of how cell and gene therapy drugs will be priced and brought to market, and methods of projecting their expected use. The team used these insights to advise its client.
Enter your contact information below and a member of our team will reach out to you shortly.
